Gastric Cancer Biomarkers: From Cellular Identity to Precision Oncology. [PDF]
Satala CB +5 more
europepmc +1 more source
Beyond PD-L1 and HER2: emerging predictive biomarkers in gastroesophageal tumors. [PDF]
Alsina M +2 more
europepmc +1 more source
Reprogramming FGFR isoform specificity in FGF2 by deep mutational scanning. [PDF]
Okada Y, Morimoto J, Sando S.
europepmc +1 more source
<i>Fgf10</i> Gene Dosage from a Single Allele Is Insufficient for Forming Multilayered Epithelial Cells in the Murine Lacrimal Gland. [PDF]
Ikeda S +7 more
europepmc +1 more source
Biological and Targeted Therapies in the Multidisciplinary Management of Gastrointestinal Cancers. [PDF]
Kos M +7 more
europepmc +1 more source
Fgfr2b signaling integrates tooth morphogenesis and dental axon patterning
Kettunen, Päivi, Luukko, Keijo
openaire +1 more source
위암에서 Fibroblast growth factor receptor 2b의 낮은 양성률과 이질적 발현 양상과의 연관성
Background: Bemarituzumab, a monoclonal antibody targeting fibroblast growth factor receptor 2b (FGFR2b), is under evaluation in phase 3 trials of gastric cancer (GC) trials. However, data on the characteristics, prognostic significance, and heterogenous
이헌우
core
A retrospective cross-sectional study of FGFR2b alterations in Chinese patients with advanced squamous non-small cell lung cancer: prevalence, programmed death-ligand 1 co-expression patterns, and association with clinical outcomes. [PDF]
Wang X +11 more
europepmc +1 more source
Developmental Therapeutics for Alveolar Generation and Regeneration: Implications for Bronchopulmonary Dysplasia and Prematurity-Associated Lung Disease. [PDF]
Warburton D +4 more
europepmc +1 more source
Correlation and Overlap Between Claudin 18.2 and FGFR2b Overexpression: A Tissue Microarray Study With 1,538 Gastric Carcinomas. [PDF]
Ahn S, Hwang I, Kim KM.
europepmc +1 more source

